Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company has a strategic collaboration with Envision Health Technologies Inc. to help advance glaucoma care through gamified virtual reality technology. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.
Latest News
Organon reports new findings from Vtama atopic dermatitis trials
FRC’s latest audit quality review suggests consolidation, says CPIA
Varta files for insolvency as German battery maker’s crisis deepens
ASCO26: AI innovations show promise in reducing the oncology RWD burden
Frasers Group acquires Greaves Sports
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Website | https://www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir |
| Audit Risk | 2 |
| Board Risk | 6 |
| Overall Risk | 7 |
| Market Cap | 2.47B |
| Trailing P/E | 20.63 |
| Forward P/E | 15.93 |
| Dividend Rate | 0.55 |
| Dividend Yield | 1.98% |
| Trailing Annual Div. Rate | 0.55 |
| Trailing Annual Div. Yield | 1.98% |
| Trailing EPS | 1.37 |
| Forward EPS | 1.77 |
| Book Value | 23.98 |
| Price-to-Book | 1.18 |
| Enterprise-to-Revenue | 1.38 |
| Enterprise-to-EBITDA | 13.84 |
| Ex-Dividend Date | 03/27/2026 |
| Earnings Date | 08/06/2026 |
| Earnings Call Date | 05/12/2026 |
| Earnings Average | 0.38 |
| Earnings Low | 0.35 |
| Earnings High | 0.4 |
| Revenue Average | 540.90M |
| Revenue Low | 528.98M |
| Revenue High | 550.00M |